AUTX-703

N/A

Report date: 2025/02/10 10:27:00
NME

Base Information

Drug NameAUTX-703
Drug Alias NameAUTX-703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone acetyltransferase KAT2A degradersHistone acetyltransferase KAT2B degraders
TargetsHistone acetyltransferase KAT2AHistone acetyltransferase KAT2B
Therapy Area/IndicationsMyelodysplastic SyndromesProstatic NeoplasmsSmall Cell Lung Carcinoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAuron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAuron Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesProstatic NeoplasmsSmall Cell Lung Carcinoma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A